Endpoint
Showing 1 - 25 of >10,000
Therapeutic Endpoint in Pediatric IBD Conditions
Not yet recruiting
- Inflammatory Bowel Diseases
- +2 more
- AlgometRx Nociometer
- (no location specified)
Sep 27, 2023
Atrial Fibrillation, Cathter Ablation, Endpoint Trial in Shanghai (AF-termination Group, Prespecified-ablation Group)
Not yet recruiting
- Atrial Fibrillation
- +2 more
- AF-termination Group
- Prespecified-ablation Group
-
Shanghai, China
- +1 more
Jun 19, 2023
Small Airways Disease in Severe Asthma asNovel Endpoint and
Recruiting
- Small Airway Disease
- Asthma
- IOS (Impulse Oscillometry)
-
Roma, ItalyFondazione Policlinico Universitario A. Gemelli
Mar 19, 2023
Congenital Myotonic Dystrophy Trial in Richmond, London, Milano (Natural history)
Recruiting
- Congenital Myotonic Dystrophy
- Natural history
-
Richmond, Virginia
- +2 more
Oct 26, 2022
Measurable Residual Disease in Acute Myeloid Leukemia as
Terminated
- Leukemia, Myeloid, Acute
- Measurable residual disease measured by flow cytometry
-
Heidelberg, BW, GermanyUniversity Hospital Heidelberg
Sep 12, 2022
Trial Readiness and Endpoint Assessment in LGMD R1
Not yet recruiting
- Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A
- +3 more
-
Richmond, VirginiaVirginia Commonwealth University
Jan 10, 2023
Ischemic Stroke Trial in Guangzhou (Aspirin, Clopidogrel, Alteplase)
Not yet recruiting
- Ischemic Stroke
- Aspirin
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Jun 11, 2023
Acute Ischemic Stroke Trial (Ginkgo Biloba Extract)
Not yet recruiting
- Acute Ischemic Stroke
- Ginkgo Biloba Extract
- (no location specified)
Nov 20, 2023
Step-up in Bronchial Asthma as a New End Point (SURFE)
Not yet recruiting
- Bronchial Asthma
- (no location specified)
Nov 19, 2022
Ischemic Stroke Trial in Beijing (Qilong capsules (QLC), produced by Jining Huaneng Pharmaceutical Factory Co., Ltd.)
Completed
- Ischemic Stroke
- Qilong capsules (QLC), produced by Jining Huaneng Pharmaceutical Factory Co., Ltd.
-
Beijing, Beijing, ChinaYanming Xie
Mar 23, 2022
Hirayama Disease Trial in New Delhi (Posterior cervical fixation surgery)
Not yet recruiting
- Hirayama Disease
- Posterior cervical fixation surgery
-
New Delhi, Delhi, IndiaDeepti Vibha
Jul 25, 2023
Ischemic Stroke Trial in Kemerovo, Sochi (Colchicine, Clopidogrel)
Recruiting
- Ischemic Stroke
-
Kemerovo, Kemerovo Region, Russian Federation
- +1 more
Oct 29, 2023
Acute Ischemic Stroke Trial in Changchun (Urinary kallidinogenase for injection, Guideline-prescribed medical therapy)
Not yet recruiting
- Acute Ischemic Stroke
- Urinary kallidinogenase for injection
- Guideline-prescribed medical therapy
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Nov 14, 2023
Acute Ischemic Stroke, Functional Outcomes Trial (Human Urinary Kallidinogenase, Clinical Routine Treatment)
Not yet recruiting
- Acute Ischemic Stroke
- Functional Outcomes
- Human Urinary Kallidinogenase
- Clinical Routine Treatment
- (no location specified)
Nov 10, 2023
Crohn Disease, Diabetic Gastroparesis Trial in Jacksonville (Rifaximin, Placebo)
Recruiting
- Crohn Disease
- Diabetic Gastroparesis
- Rifaximin
- Placebo
-
Jacksonville, FloridaMayo Clinic in Florida
Dec 12, 2022
COVID-19 Trial (Recommended treatment schedule, Usual care)
Not yet recruiting
- COVID-19
- Recommended treatment schedule
- Usual care
- (no location specified)
Nov 2, 2022
Depression, Depressive Symptoms, Mood Trial in Boston (vitamin D3, omega-3 fatty acids (fish oil), Fish oil )
Active, not recruiting
- Depression
- +2 more
- vitamin D3
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Feb 28, 2022
Stroke, Acute Ischemic Trial in Shenyang (head-down position)
Not yet recruiting
- Stroke, Acute Ischemic
- head-down position
-
Shenyang, ChinaDepartment of Neurology, General Hospital of Northern Theater Co
Aug 23, 2023
Stroke, Ischemic Trial in Shenyang (Tenecteplase)
Not yet recruiting
- Stroke, Ischemic
-
Shenyang, ChinaDepartment of Neurology, General Hospital of Northern Theater Co
Aug 23, 2023
Acute Ischemic Stroke, Basilar Artery Occlusion Trial in Beijing (Best medical management, Endovascular treatment)
Recruiting
- Acute Ischemic Stroke
- Basilar Artery Occlusion
- Best medical management
- Endovascular treatment
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Oct 20, 2023
System of Clinical Endpoint Events for Chronic Hepatitis B
Active, not recruiting
- Chronic Hepatitis b
-
Beijing, Beijing, China
- +6 more
Sep 2, 2022
Intracranial Aneurysm, Cerebrovascular Disease Trial in Beijing (Aspirin Enteric-coated Tablets)
Not yet recruiting
- Intracranial Aneurysm
- Cerebrovascular Disease
- Aspirin Enteric-coated Tablets
-
Beijing, Beijing, China
- +1 more
Jun 14, 2023
Acute Ischemic Stroke Trial in Beijing (Bailout angioplasty, thrombectomy alone)
Recruiting
- Acute Ischemic Stroke
- Bailout angioplasty
- thrombectomy alone
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Oct 31, 2022